EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte Studie

Clesrovimab for Prevention of RSV Disease in Healthy Infants

Heather J Zar iD, Eric A F Simões, Shabir A Madhi iD, Octavio Ramilo, Shelly D Senders, Julie S Shepard, Kamolwish Laoprasopwattana, Jorge Piedrahita, Jose M Novoa, Sergio L Vargas, Marc Dionne, Teresa Jackowska und 13 weitere

New England Journal of Medicine · 02.10.2025 · 393 (13) · 1292-1303

DOI: 10.1056/nejmoa2502984 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 02.10.2025. Verfasst von Heather J Zar und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Child Health and Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antiviral Agents, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Merck.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedAntiviral AgentsRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanFemaleHumansInfantInfant, NewbornMaleDouble-Blind MethodHospitalizationInfant, PrematureInjections, IntramuscularRespiratory Tract InfectionsViral Fusion ProteinsDrugs, InvestigationalSeverity of Illness IndexIncidenceFollow-Up Studies

Substanzen

Antibodies, Monoclonal, HumanizedAntiviral AgentsViral Fusion ProteinsDrugs, Investigational

Autor:innen und Institutionen

  • Department of Pediatrics and Child Health and Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.
  • Children's Hospital Colorado and the University of Colorado School of Medicine, Aurora.
  • South African Medical Research Council: Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg.
  • St. Jude Children's Research Hospital, Memphis, TN.
  • Senders Pediatrics, Cleveland.
  • Ohio Pediatric Research Association, Dayton.

ORCID-Profile: Heather J Zar, Shabir A Madhi, Brian M Maas

Förderung

  • Merck

Zitieren

APA

Zar, H. J., Simões, E. A. F., Madhi, S. A., Ramilo, O., Senders, S. D., Shepard, J. S., Laoprasopwattana, K., Piedrahita, J., Novoa, J. M., Vargas, S. L., Dionne, M., Jackowska, T., Liu, E., Ishihara, Y., Ikeda, K., Zhang, Y., Railkar, R. A., Lutkiewicz, J., Vora, K. A., …, & CLEVER (MK-1654-004) Study Group (2025). Clesrovimab for Prevention of RSV Disease in Healthy Infants. New England Journal of Medicine, 393(13), 1292-1303. https://doi.org/10.1056/nejmoa2502984

Vancouver

Zar HJ, Simões EAF, Madhi SA, Ramilo O, Senders SD, Shepard JS, et al. Clesrovimab for Prevention of RSV Disease in Healthy Infants. New England Journal of Medicine. 2025;393(13):1292-1303. doi:10.1056/nejmoa2502984

BibTeX
@article{Zar2025,
  author = {Zar, Heather J and Simões, Eric A F and Madhi, Shabir A and Ramilo, Octavio and Senders, Shelly D and Shepard, Julie S and Laoprasopwattana, Kamolwish and Piedrahita, Jorge and Novoa, Jose M and Vargas, Sergio L and Dionne, Marc and Jackowska, Teresa and Liu, Enmei and Ishihara, Yasunori and Ikeda, Kazushige and Zhang, Ying and Railkar, Radha A and Lutkiewicz, Jeannine and Vora, Kalpit A and Zang, Xiaowei and Maas, Brian M and Lee, Andrew W and Guerra, Andrea and Sinha, Anushua and CLEVER (MK-1654-004) Study Group, CLEVER (MK-1654-004) Study Group},
  title = {Clesrovimab for Prevention of RSV Disease in Healthy Infants},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {13},
  pages = {1292--1303},
  doi = {10.1056/nejmoa2502984}
}
Kostenlos starten →